Nasal Lacrimal Stent Market
According to Intent Market Research, the Nasal Lacrimal Stent Market is expected to grow from USD 1.1 Billion in 2024-e at a CAGR of 9.8% to touch USD 1.9 Billion by 2030. The Nasal Lacrimal Stent Market is dominated by key players such as Stryker Corporation, CooperVision, Inc., Smith & Nephew plc, Medtronic PLC, Bausch Health Companies Inc., and Thermo Fisher Scientific Inc.